Adaptive Biotechnologies is joining the horde of biotechs that have been forced to lay off staff in the wake of growing market challenges.
The Seattle biotech announced Wednesday it will trim its workforce by about 12%, which would equal about 100 employees. In addition, it’s conducting a widespread reorganization of...
